Us

Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds CCXI Investors for Securities Fraud Class Action Lawsuit

Saturday, June 12, 2021 - 7:11pm

For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.

Key Points: 
  • For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.
  • Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .

EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Action

Saturday, June 12, 2021 - 5:06pm

SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now .
  • 31, 2021, media reports revealed the company mixed up ingredients for J&Js and AstraZenecas vaccines, contaminating up to 15 million J&J vaccine doses.
  • Were focused on investors losses and proving Emergent lied about its vaccine production capabilities, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

HAGENS BERMAN Alerts Danimer Scientific (DNMR) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact its Attorneys Now

Saturday, June 12, 2021 - 5:05pm

SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Danimer Scientific, Inc. (NYSE: DNMR) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Danimer Scientific, Inc. (NYSE: DNMR) investors with significant losses to submit your losses now .
  • 20, 2021, when the Wall Street Journal reported that many claims about Nodax are exaggerated and misleading.
  • Were focused on investors losses and proving Danimer misled investors by greenwashing and misstating its true performance metrics, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

HAGENS BERMAN Alerts Aterian (ATER) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact the Firm Now

Saturday, June 12, 2021 - 4:01pm

The truth emerged on May 4, 2021, when analyst Culper Research published a scathing report entitled Aterian (ATER): Bought from Felons & Fraudsters, Sold to You.

Key Points: 
  • The truth emerged on May 4, 2021, when analyst Culper Research published a scathing report entitled Aterian (ATER): Bought from Felons & Fraudsters, Sold to You.
  • Were focused on investors losses and proving Aterian misled investors about its acquisitions and the AIMEE platform, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you are an Aterian investor and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

HAGENS BERMAN Alerts ChemoCentryx (CCXI) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors with Losses Should Contact the Firm

Saturday, June 12, 2021 - 4:05pm

ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action:

Key Points: 
  • ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action:
    The lawsuit focuses on ChemoCentryxs statements about its new drug application (NDA) for its vasculitis drug candidate Avacopan.
  • Were focused on investors losses and proving ChemoCentryx misled investors about Avacopans efficacy and safety, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you are a ChemoCentryx investor and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

RMO 3-DAY DEADLINE ALERT: Hagens Berman Encourages Romeo Power (RMO) Investors with Losses to Contact the Firm Before June 15th Deadline in Securities Class Action

Saturday, June 12, 2021 - 4:35pm

SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Romeo Power, Inc. (NYSE: RMO) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Romeo Power, Inc. (NYSE: RMO) investors with significant losses to submit your losses now .
  • A securities class action has been filed and certain investors may have valuable claims.
  • The company repeatedly assured investors it had sufficient long-term contracts to supply enough battery cells even in the face of the tight supply.
  • Were focused on investors losses and proving Romeo concealed supply chain risks, said Reed Kathrein, the Hagens Berman partner leading the investigation.

ACAD 6-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, Deadline Approaching in Securities Class Action

Saturday, June 12, 2021 - 4:16pm

SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now .
  • Thereafter, the company repeatedly stated the FDA had not identified any potential review issues and reiterated the drugs efficacy.
  • Were focused on investors losses and proving Acadia misled investors by concealing FDA-related review risks for the sNDA, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.

HAGENS BERMAN Alerts Skillz (SKLZ) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact its Attorneys Now

Saturday, June 12, 2021 - 4:35pm

Skillz, Inc. (NYSE: SKLZ) Securities Fraud Class Action:

Key Points: 
  • Skillz, Inc. (NYSE: SKLZ) Securities Fraud Class Action:
    In past months, Skillz and senior management repeatedly touted the companys revenue growth and projections to support its valuation.
  • Were focused on investors losses and proving Skillz engaged in fraudulent accounting and financial reporting, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you are a Skillz investor and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ubiquiti Inc. (UI) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact its Attorneys Now

Saturday, June 12, 2021 - 3:35pm

Ubiquiti Inc. (NYSE: UI) Securities Fraud Class Action:

Key Points: 
  • Ubiquiti Inc. (NYSE: UI) Securities Fraud Class Action:
    The complaint centers on Defendants false disclosures concerning the nature and scope of a serious security breach incident at Ubiquiti.
  • Defendants also downplayed the seriousness of the incident and repeatedly stated that they only became aware of the breach in Jan. 2021.
  • Were focused on investors losses and proving Ubiquiti intentionally misrepresented the security of a core business, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

CAN DEADLINE MONDAY: Hagens Berman Encourages Canaan (CAN) Investors with Losses to Contact the Firm Before June 14th Deadline in Securities Fraud Lawsuit

Saturday, June 12, 2021 - 3:45pm

9, 2021, Canaans CEO reportedly assured investors that the global shortage of chips used in its equipment did not negatively impact the company.

Key Points: 
  • 9, 2021, Canaans CEO reportedly assured investors that the global shortage of chips used in its equipment did not negatively impact the company.
  • Were focused on investors losses and proving Canaan intentionally and falsely assured investors of its forecasted revenues and its insulation from the chip shortage, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you are a Canaan investor and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.